Peng Lee

New York University

Papers

1

Total Citations

16

H-Index

1

About

Peng Lee is a leading pathologist and researcher whose work centers on prostate cancer biology, biomarker discovery, and the development of standardized biobanking protocols to accelerate translational research. As a key figure in the Prostate Cancer Biorepository Network (PCBN), he has been instrumental in establishing rigorous, reproducible methods for collecting and annotating high-quality tissue specimens from radical prostatectomy procedures, including both open and robot-assisted laparoscopic approaches. His highly cited 2013 paper on biobanking derivatives from these surgeries has provided a foundational framework for the field, ensuring that specimens are systematically processed and linked to robust clinical data. This work has enabled countless downstream studies on prostate cancer genomics, progression markers, and therapeutic targets. With over 16 citations on this seminal protocol alone, Lee’s contributions have had a lasting impact on the infrastructure of prostate cancer research. His commitment to quality-controlled biospecimen resources continues to empower investigators worldwide, bridging the gap between surgical pathology and molecular discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Biobanking of derivatives from radical retropubic and robot‐assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network
16 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: New York University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago